These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33313340)

  • 1. Stochastic models for objects and images in oncology and virology: application to PI3K-Akt-mTOR signaling and COVID-19 disease.
    Barrett HH; Caucci L
    J Med Imaging (Bellingham); 2021 Jan; 8(Suppl 1):S16001. PubMed ID: 33313340
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum: Publisher's Note: Stochastic models for objects and images in oncology and virology: application to PI3K-Akt-mTOR signaling and COVID-19 disease.
    Barrett HH; Caucci L
    J Med Imaging (Bellingham); 2021 Jan; 8(Suppl 1):019801. PubMed ID: 33409337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic anatomy recognition in whole-body PET/CT images.
    Wang H; Udupa JK; Odhner D; Tong Y; Zhao L; Torigian DA
    Med Phys; 2016 Jan; 43(1):613. PubMed ID: 26745953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PI3k/Akt/mTOR Signaling Induces Deposition of p-tau to Promote Aluminum Neurotoxicity.
    Xu Y; Zhang G; Zhao Y; Bu F; Zhang Y
    Neurotox Res; 2022 Oct; 40(5):1516-1525. PubMed ID: 36066748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy.
    Fattahi S; Khalifehzadeh-Esfahani Z; Mohammad-Rezaei M; Mafi S; Jafarinia M
    Immunol Res; 2022 Jun; 70(3):269-275. PubMed ID: 35107743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Singular value decomposition for photon-processing nuclear imaging systems and applications for reconstruction and computing null functions.
    Jha AK; Barrett HH; Frey EC; Clarkson E; Caucci L; Kupinski MA
    Phys Med Biol; 2015 Sep; 60(18):7359-85. PubMed ID: 26350439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention.
    Roudsari NM; Lashgari NA; Momtaz S; Abaft S; Jamali F; Safaiepour P; Narimisa K; Jackson G; Bishayee A; Rezaei N; Abdolghaffari AH; Bishayee A
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertical inhibition of PI3K/Akt/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity.
    Liang M; Lv J; Chu H; Wang J; Chen X; Zhu X; Xue Y; Guan M; Zou H
    J Dermatol Sci; 2014 Nov; 76(2):104-11. PubMed ID: 25258031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automatic cumulative sums contour detection of FBP-reconstructed multi-object nuclear medicine images.
    Protonotarios NE; Spyrou GM; Kastis GA
    Comput Biol Med; 2017 Jun; 85():43-52. PubMed ID: 28433871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19.
    Basile MS; Cavalli E; McCubrey J; Hernández-Bello J; Muñoz-Valle JF; Fagone P; Nicoletti F
    Drug Discov Today; 2022 Mar; 27(3):848-856. PubMed ID: 34763066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
    Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segmentation of stochastic images with a stochastic random walker method.
    Pätz T; Preusser T
    IEEE Trans Image Process; 2012 May; 21(5):2424-33. PubMed ID: 22334006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities.
    Wiese W; Barczuk J; Racinska O; Siwecka N; Rozpedek-Kaminska W; Slupianek A; Sierpinski R; Majsterek I
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.
    Martelli AM; Tazzari PL; Evangelisti C; Chiarini F; Blalock WL; Billi AM; Manzoli L; McCubrey JA; Cocco L
    Curr Med Chem; 2007; 14(19):2009-23. PubMed ID: 17691943
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.